Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomitant Antiepileptic Drugs
Links shared publicly online about this topic.
- 584total visits
Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomitant Antiepileptic Drugs
View full resource at medicalnewstoday.com
Most Recently Shared on January 14, 2011 at 5:41 am By:
Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Conc... http://bit.ly/i00psV
Also Shared By:
Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years
medicalnewstoday.com — “The 29th International Epilepsy Congress in Rome, Italy (28th August-1st September) 1-4 presented consistent evidence this week, that a combined treatment with Vimpat® (lacosamide) has general” View full resource at medicalnewstoday.com
Most Recently Shared on September 2, 2011 at 7:04 am By:
Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years: The 29th ... http://t.co/Mec2KWC
Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures - Drugs.com MedNews
drugs.com — “Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress New non-interventional study (VITOBA ) aims” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 10:01 pm By:
Drugs and Devices OW OW Health
Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with p... http://t.co/oazh0jZ #drug
UCB Media Centre - Vimpat® (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures
ucb.presscentre.com — “For the attention of accredited medical writers only• Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress • New non-interventional study (VITOBA™) aims to investigate additive or synergistic effects of lacosamide with single antiepileptic drug (AED) treatment” View full resource at ucb.presscentre.com
Most Recently Shared on August 31, 2011 at 12:24 pm By:
Actually the UCB/Vimpat link is this: http://t.co/Sgp6Aff
Epilepsy Treatment & Seizure Control
vimpat.com — “Learn how VIMPAT may help you get better partial-onset seizure control. Click here for more information.” View full resource at vimpat.com
Most Recently Shared on June 28, 2011 at 12:29 pm By:
Walter Jessen - Highlight HEALTH Health Organization and Health Executive
Vimpat (lacosamide) http://ow.ly/1duIRn
Hospital Pharmacy Europe - UCB commitment to epilepsy community
hospitalpharmacyeurope.com — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at hospitalpharmacyeurope.com
Most Recently Shared on February 15, 2011 at 1:33 am By:
UCB commitment to epilepsy community: Marking "100,000 patients treated" milestone for Vimpat® (lacosamide) in ... http://bit.ly/fOuWsk
Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of Concomitant Antiepileptic Drugs - Drugs.com MedNews
drugs.com — “Comprehensive lacosamide analyses published in CNS Drugs - Pooled phase II III clinical trial data demonstrated efficacy and tolerability of lacosamide as adjun” View full resource at drugs.com
Most Recently Shared on January 12, 2011 at 7:18 pm By:
Drugs and Devices OW OW Health
Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of ... http://bit.ly/dQh82u #drug
Long-term Use of Antiepileptic Drug Vimpat (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Frequency and Improved Health-related Quality of Life - Drugs.com MedNews
drugs.com — “Data presented at the 64th Annual Meeting of the American Epilepsy Society - First presentation of the effects of long-term Vimpat treatment on patients self-re” View full resource at drugs.com
Most Recently Shared on December 7, 2010 at 9:07 pm By:
Drugs and Devices OW OW Health
Long-term Use of Antiepileptic Drug Vimpat (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Freq... http://bit.ly/gFrSKZ #drug
New Data On Vimpat® (lacosamide) C-V To Be Presented At The 64th Annual Meeting Of The American Epilepsy Society
medicalnewstoday.com — “New data on UCB's anti-epileptic drug (AED) Vimpat® (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Conven” View full resource at medicalnewstoday.com
Most Recently Shared on December 1, 2010 at 5:05 pm By:
New Data On Vimpat® (lacosamide) C-V To Be Presented At The 64th Annual Meeting Of The American Epilepsy Society http://mnt.to/3NmQ
New Data on Vimpat (lacosamide) C-V to be Presented at the 64th Annual Meeting of the American Epilepsy Society - Drugs.com MedNews
drugs.com — “Data on Keppra XR (levetiracetam) extended release tablets and Brivaracetam will also be presented New data on UCB s anti-epileptic drug (AED) Vimpat (lacosamid” View full resource at drugs.com
Most Recently Shared on November 30, 2010 at 4:15 pm By:
Drugs and Devices OW OW Health
New Data on Vimpat (lacosamide) C-V to be Presented at the 64th Annual Meeting of the American Epilepsy So... http://bit.ly/hr1oKI #drug
Somebody Heal Me: Vimpat for Migraine Prevention
somebodyhealme.dianalee.net — “Somebody Heal Me: Vimpat for Migraine Prevention” View full resource at somebodyhealme.dianalee.net
Most Recently Shared on October 21, 2010 at 9:45 pm By:
Somebody Heal Me: Vimpat for Migraine Prevention http://t.co/DVqXgTp via @somebodyhealme
Migraine - Vimpat for Migraine and Headache Prevention
healthcentral.com — “At this time, there are no medications on the market that were developed specifically for Migraine and headache prevention. We use medications that were origi...” View full resource at healthcentral.com
Most Recently Shared on August 11, 2010 at 8:59 pm By:
This is what I'm taking for prevention - Migraine - Vimpat for Migraine and Headache Prevention: http://bit.ly/cu4NHP
New Data For Vimpat (Lacosamide) C-V Showed Sustained Efficacy For Up To 5 Years
medicalnewstoday.com — “New long term data showed that Vimpat® (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset s” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2010 at 5:08 pm By:
New Data For Vimpat (Lacosamide) C-V Showed Sustained Efficacy For Up To 5 Years http://mnt.to/3Fzh #epilepsy
Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs
news-medical.net — “New long term data showed that Vimpat- (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs) including both traditional sodium channel-blocking agents and ” View full resource at news-medical.net
Most Recently Shared on June 30, 2010 at 12:59 pm By:
Epilepsy News: Vimpat provides long-term additional partial-onset seizure control when added to broad range of AED... http://bit.ly/bDYwk4
New Oral Solution Formulation Of Antiepileptic Drug Vimpat (Lacosamide) (C-V)
medicalnewstoday.com — “UCB has announced the availability of an oral solution formulation of Vimpat® (lacosamide) C-V, an antiepileptic drug (AED) for add-on treatment of partial-onset seizures in people with epilep” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2010 at 12:14 pm By:
MNT Caregivers News Health News
New Oral Solution Formulation Of Antiepileptic Drug Vimpat (Lacosamide) (C-V) http://mnt.to/3DVb #caregivers
Advertisement
MNT Pharma News
@mnt_pharma
New Data On Vimpat® (lacosamide) C-V To Be Presented At The 64th Annual Meeting Of The American Epilepsy Society http://mnt.to/3NmQ
1 year ago...